Leading Companies in India Metoprolol Market | Key Players & Insights 2026

India Metoprolol Market Overview

According to 6Wresearch, the India metoprolol market is poised for robust growth, driven by the escalating burden of cardiovascular diseases (CVDs) and hypertension in the Indian population. Metoprolol, a critical beta-blocker, is increasingly used in dual-action combination treatments, particularly with Telmisartan and Amlodipine. The market is also driven by the increasing adoption of Sustained Release (SR) and Extended Release (ER) technologies, which improve patient compliance through once-daily dosing.

Competitive Landscape

The competitive landscape of the India metoprolol market is defined by a blend of large-scale formulation giants and specialized API suppliers. Strategic depth in the market is characterized by vertical integration, where firms produce both the active ingredient and the final dosage form to maintain cost leadership.

Below is a list of leading players operating in the India Metoprolol Market:

1. Cipla Limited

A global respiratory and cardiac leader, Cipla dominates the domestic segment with its widely prescribed Met XL and Metolar XR brands.

2. Ipca Laboratories Limited

A major force in cardiovascular care, Ipca manufactures the popular Revelol brand and maintains strong vertical integration for beta-blocker APIs.

3. USV Private Limited

Recognized for its high-quality therapeutic solutions, USV's Starpress XL is a market leader in the extended-release metoprolol succinate segment.

4. Sun Pharmaceutical Industries Limited

The largest Indian pharma company globally, Sun Pharma provides complex formulations like Prolomet XL through its vast distribution network.

5. Dr. Reddy's Laboratories Ltd.

A multinational giant that leverages its API expertise to supply high-purity metoprolol products like Betaone XL to domestic and international markets.

6. Lupin Limited

Lupin holds a significant share in the chronic disease segment, focusing on advanced drug delivery systems for brands like Metpure XL.

7. AstraZeneca Pharma India Limited

As the originator of the Seloken XL brand, AstraZeneca remains a benchmark for quality in the premium metoprolol succinate market.

8. Ajanta Pharma Limited

Specializes in high-margin specialty products, including the Met XL D range which combines metoprolol with modern metabolic regulators.

9. Alembic Pharmaceuticals Limited

One of India's oldest pharma firms, Alembic produces a range of metoprolol generics with a focus on modern, automated manufacturing facilities.

10. Torrent Pharmaceuticals Limited

A leader in the cardiovascular market, Torrent specializes in fixed-dose combinations that pair metoprolol with modern antihypertensives.